In the January 9 episode of Beyond the Gates, Anita began her chemotherapy, while Nicole and Dani learned if they carried the ...

Secrets unravel, threats escalate and a shocking genetic discovery challenges the Dupree family in this week’s Beyond the ...

Here's what went down Friday, January 9, 2026 on Beyond the Gates when Martin became aware of his mom's status change, an ...

In this study, researchers aimed to determine whether younger BRCA1/2 carriers who undergo oophorectomy can receive menopausal hormone therapy without increasing their risk of breast cancer.

Fast Track designation granted by U.S. FDA for evaluation of ETX-19477 in patients with BRCA-mutated, platinum-resistant ...

Next week on Beyond the Gates, the Duprees let loose a little, but unfortunately for the family, there is a shadow hanging ...

The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...

Women with the BRCA gene mutations have a 60 to 80 percent chance of developing /topics/Breast_Cancer" class="cnnInlineTopic">breast cancer-- at least five times higher than the general population -- ...

While that might sound a good thing, the truth is a bit more complicated. For starters, not everyone needs to get tested, as these gene mutations are still fairly rare, affecting only about 1 in 400 ...

Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited mutations in the BRCA1 or BRCA2 genes, according to the results of a matched ...